China
R&G Pharmastudies is a pharmaceutical company founded in 2008 in China, with a mission to enhance global pharmaceutical research efficiency through comprehensive analysis, clinical research, and data management services. Specializing in Analytics, Data Analytics, Medical Devices, and Pharmaceutical industries, the company offers clinical research outsourcing solutions for global pharmaceutical and medical device companies, as well as scientific research institutions.
The primary goal of R&G Pharmastudies is to aid pharmaceutical research and development firms in reducing costs, shortening development cycles, and enhancing the success rates of their projects. With a focus on comprehensive analysis, clinical research, and data management, the company aims to streamline the research and development processes within the industry, ultimately contributing to the advancement of pharmaceutical and medical innovations.
Currently, there is no public information available regarding the last investment and the investors associated with R&G Pharmastudies. However, given the company's strong foothold in the pharmaceutical research sector and its dedication to improving research efficiency, it presents an intriguing opportunity for potential investors looking to support advancements in healthcare and pharmaceuticals.
